Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Surgery
Share your love
FDA Grants Breakthrough and RMAT Status to Aurion’s AURN001
Aurion Biotech has been granted Breakthrough Therapy Designation (BTD) and Regenerative Medicine Advanced Therapy (RMAT) Designation by the FDA for AURN001, Aurion’s innovative allogeneic cell therapy candidate designed to treat corneal edema secondary to corneal endothelial disease. Expediting Development and…
Preseptal and Orbital Cellulitis | OBN
Preseptal cellulitis (periorbital cellulitis) is infection of the eyelid and surrounding skin anterior to the orbital septum. Orbital cellulitis is infection of the orbital tissues posterior to the orbital septum. Either can be caused by an external focus of infection (eg, a wound),…
Teprotumumab Shows Long-Lasting Benefits for TED Patients
Research presented at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Massachusetts, and published in the journal Thyroid, indicates that most patients with thyroid eye disease (TED) treated with teprotumumab did not require additional treatments nearly two years later.…
Australia’s 2nd Generation Bionic Eye Shows Promise in RP
Australia’s second-generation bionic eye has demonstrated “substantial improvement” in functional vision, daily activities, and quality of life for four participants over a period of more than two and a half years, according to the results of the first clinical trial.…
What Is Lens Replacement Surgery?
Lens replacement surgery, also known as Refractive Lens Exchange (RLE) or Clear Lens Extraction (CLE), is a procedure designed to improve vision by replacing the eye’s natural lens with an artificial one. This surgery is particularly beneficial for those who…
Your Complete Guide to Cataract Surgery
Cataract surgery is a safe, effective procedure that improves vision by removing cloudy lenses from the eyes and replacing them with artificial lenses. As technology advances and techniques improve, understanding the nuances of cataract surgery is crucial for anyone considering…
Melt Pharmaceuticals Launches MELT-300 Phase 3 Program
Melt Pharmaceuticals has completed the dosing of its first patient in its phase 3 program for MELT-300, marking a crucial step in evaluating the safety and efficacy of this pioneering product. MELT-300 is a non-intravenous, non-opioid tablet comprising fixed doses…
Phase 3 Trial for AZR-MD-001 in MGD Patients Begins
Azura Ophthalmics has reached a significant milestone with the enrollment of the first patient in the ASTRO study—a phase 3 clinical trial evaluating the efficacy and safety of AZR-MD-001 in patients grappling with clinical signs and symptoms of meibomian gland…
Sightpath Medical Acquires PennVista | OBN
Sightpath Medical, a leading provider of mobile and fixed ophthalmic surgical services, has recently completed the acquisition of PennVista, a renowned LASIK services business. PennVista specializes in offering cutting-edge equipment and skilled technicians to surgery centers and hospitals across Pennsylvania,…
Quantel Medical Launches POCKET III
Quantel Medical, a division of Lumibird Medical, has unveiled its latest innovation with the launch of the POCKET III handheld pachymeter. This compact device, according to Quantel, sets a new standard as the lightest connected handheld pachymeter on the market,…